(Allergan plc)

	AGN latest price $279.3570 (1.92%) ($271.7033 - $281.0847) on Thu. Feb. 19, 2015.
	Trend Analysis and Forecast
Average Daily Percentage Swing	1.52% (three month average)
RSI	64
Latest Price	$279.3570(1.92%)
Stocks Behave Similarly	Similar Stock List
Daily Trend	AGN advances 0.8% a day on average for past five trading days.
Weekly Trend	AGN advances 3.2% a week on average for past two weeks.
Market Behavior	Normal for large cap. Normal for small cap.
Correlated ETFs	Broad market will support AGN advance at 0% a week (0% probability)   XLV(55%)    IBB(54%)    XBI(47%)    SPY(43%)    QQQ(42%)
Factors Impacting AGN price	AGN will decline at least -0.76% in a week (0% probabilities).   VIXM(-31%)    TLT(-18%)    SHY(-7%)    UUP(-6%)    IGOV(-4%)
Explanation	The rally is not sustainable and not supported by the broad market.
Relative Volatility	(options are extremely cheap)
Market Trend Strength	-0.76% (StdDev 1.52%)
Hourly BBV	0 ()
Intraday Trend	2.8%

5 Day Moving Average	$275.53(1.39%)
10 Day Moving Average	$271.27(2.98%)
20 Day Moving Average	$267.81(4.31%)
To recent high	0%
To recent low	13.9%
Market Cap	$92.104b

Allergan Plc engages in the research, development, and manufacture of pharmaceutical products. It operates through the following business segments: US Specialized Therapeutics; US General Medicine, and International. The US Specialized Therapeutics segment includes sales and expenses relating to branded products within the United States. The US General Medicine segment involves Central Nervous System; Gastrointestinal; Women's Health; Anti-Infectives; and Diversified brands. The International segment comprises of products sold outside the United States. The company was founded in 1984 and is headquartered in Dublin, Ireland.

getNextHourMoveProbability failed